Vericel (VCEL) Cash & Equivalents (2010 - 2026)

Vericel has disclosed Cash & Equivalents across 15 years of filings, most recently posting $109.3 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $109.3 million, up 48.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $109.3 million (up 48.72% YoY), and the FY2025 annual result was $100.1 million, up 34.32% from the prior year.
• Cash & Equivalents came in at $109.3 million for Q1 2026 at Vericel, up from $100.1 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $109.3 million in Q1 2026 to a low of $43.0 million in Q2 2023.
• The 5-year median for Cash & Equivalents is $62.9 million (2024), against an average of $68.7 million.
• Across the five-year window, Cash & Equivalents fell 25.26% in 2022 and soared 87.04% in 2025, its largest moves.
• Vericel's Cash & Equivalents stood at $51.1 million in 2022, then surged by 35.29% to $69.1 million in 2023, then gained by 7.86% to $74.5 million in 2024, then jumped by 34.32% to $100.1 million in 2025, then advanced by 9.19% to $109.3 million in 2026.
• The last three Cash & Equivalents figures came in at $109.3 million (Q1 2026), $100.1 million (Q4 2025), and $100.4 million (Q3 2025), per Business Quant data.